ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,589.67
      -0.44%
      US Tech 100
      19,006.52
      0.51%
      Dow Jones
      41,509.05
      -0.96%
      Brent Oil
      69.405
      0.53%
      Bitcoin
      82,496.10
      5.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Krystal Biotech Inc (KRYS) Quote

      Krystal Biotech Inc

      Krystal Biotech Inc (KRYS)

      NASDAQ
      184.07
      0.32
      ( 0.17% )
      Updated: 14:22:31
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      184.07
      Bid
      183.77
      Ask
      184.32
      Volume
      184,743
      179.33 Day's Range 186.95
      141.72 52 Week Range 219.34
      Market Cap
      5.302B
      Previous Close
      183.75
      Open
      184.87
      Last Trade
      50
      @
      184.175
      Last Trade Time
      14:22:31
      Financial Volume
      $ 33,595,694
      VWAP
      181.851
      Average Volume (3m)
      274,450
      Shares Outstanding
      28,806,078
      Dividend Yield
      -
      PE Ratio
      58.83
      Earnings Per Share (EPS)
      3.1
      Revenue
      290.52M
      Net Profit
      89.16M

      About Krystal Biotech Inc

      Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments... Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on development of easy to use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.krystalbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Krystal Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker KRYS. The last closing price for Krystal Biotech was $183.75. Over the last year, Krystal Biotech shares have traded in a share price range of $ 141.72 to $ 219.34.

      Krystal Biotech currently has 28,806,078 shares outstanding. The market capitalization of Krystal Biotech is $5.29 billion. Krystal Biotech has a price to earnings ratio (PE ratio) of 58.83.

      Ask ADVFN Intelligence (AI)

      Krystal Biotech (KRYS) Options Flow Summary

      KRYS Options Flow

      Overall Flow

      Bullish

      Net Premium

      35k

      Calls / Puts

      100.00%

      Buys / Sells

      100.00%

      OTM / ITM

      100.00%

      Sweeps Ratio

      0.00%

      KRYS Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 28 2025
      KRYS (0.17%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 28 2025
      KRYS (0.17%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      February 27 2025
      KRYS (0.17%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 19 2025
      KRYS (0.17%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      February 19 2025
      KRYS (0.17%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      113.627.99061308302170.45186.95167.5401285733179.72757539CS
      431.7220.8204791598152.35190146305047174.53966241CS
      1218.3111.0460907336165.76190141.72274450163.56914127CS
      26-1.27-0.685227150103185.34207.84141.72258525173.47238807CS
      5212.026.98634117989172.05219.34141.72296319176.09442151CS
      156117.63177.04695966366.44219.3447.67262696128.12243755CS
      260130.62244.37792329353.45219.3433.0848231240106.26769073CS

      KRYS - Frequently Asked Questions (FAQ)

      What is the current Krystal Biotech share price?
      The current share price of Krystal Biotech is $ 184.07
      How many Krystal Biotech shares are in issue?
      Krystal Biotech has 28,806,078 shares in issue
      What is the market cap of Krystal Biotech?
      The market capitalisation of Krystal Biotech is USD 5.29B
      What is the 1 year trading range for Krystal Biotech share price?
      Krystal Biotech has traded in the range of $ 141.72 to $ 219.34 during the past year
      What is the PE ratio of Krystal Biotech?
      The price to earnings ratio of Krystal Biotech is 58.83
      What is the cash to sales ratio of Krystal Biotech?
      The cash to sales ratio of Krystal Biotech is 18.05
      What is the reporting currency for Krystal Biotech?
      Krystal Biotech reports financial results in USD
      What is the latest annual turnover for Krystal Biotech?
      The latest annual turnover of Krystal Biotech is USD 290.52M
      What is the latest annual profit for Krystal Biotech?
      The latest annual profit of Krystal Biotech is USD 89.16M
      What is the registered address of Krystal Biotech?
      The registered address for Krystal Biotech is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Krystal Biotech website address?
      The website address for Krystal Biotech is www.krystalbio.com
      Which industry sector does Krystal Biotech operate in?
      Krystal Biotech operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RAYRaytech Holding Ltd
      $ 1.95
      (124.14%)
      		89.5M
      SYRSSyros Pharmaceuticals Inc
      $ 0.1658
      (81.00%)
      		649.84M
      TSVT2seventy bio Inc
      $ 4.945
      (76.61%)
      		28.77M
      HSAIHesai Group
      $ 23.60
      (47.41%)
      		22.3M
      TNONTenon Medical Inc
      $ 1.805
      (44.40%)
      		31.59M
      WCTWellchange Holdings Company Limited
      $ 0.69
      (-72.51%)
      		28.83M
      ARVNArvinas Inc
      $ 8.4555
      (-51.85%)
      		13.56M
      LZMHLZ Technology Holdings Ltd
      $ 9.2141
      (-41.16%)
      		487.33k
      SPGCSacks Parente Golf Inc
      $ 0.10395
      (-35.07%)
      		31.74M
      KBSXFST Corporation
      $ 3.84
      (-27.55%)
      		49.47k
      SYRSSyros Pharmaceuticals Inc
      $ 0.1659
      (81.11%)
      		656.69M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0394
      (17.61%)
      		386.14M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 8.08
      (9.49%)
      		250.68M
      NVDANVIDIA Corporation
      $ 110.14
      (2.95%)
      		248.12M
      CUTRCutera Inc
      $ 0.109
      (-15.18%)
      		209.36M

      KRYS Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      KRYS. Under $200
      👍️0
      Monksdream Monksdream 7 months ago
      KRYS new 52 week high
      👍️0
      Monksdream Monksdream 10 months ago
      KRYS 10Q due 5/6
      👍️0
      Monksdream Monksdream 11 months ago
      KRYS over $30
      👍️0
      Monksdream Monksdream 1 year ago
      KRYS new 52 week high
      👍️0
      Monksdream Monksdream 2 years ago
      From Cathie Wood
      A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
      ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
      Research Associate
      Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

      Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
      👍️0
      wiredawg wiredawg 3 years ago
      Moving nicely today...
      👍️0
      wiredawg wiredawg 3 years ago
      Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
      👍️0
      wiredawg wiredawg 3 years ago
      In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

      👍️0
      wiredawg wiredawg 3 years ago
      30 Nov Tues releases this PR during evening after market close:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
      👍️0
      wiredawg wiredawg 3 years ago
      29 Nov Mon after market closes release this PR:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
      👍️0
      wiredawg wiredawg 3 years ago
      29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
      👍️0
      wiredawg wiredawg 3 years ago
      This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
      👍️0
      wiredawg wiredawg 3 years ago
      Holding well so far, why the pretty hard drop?
      👍️0
      wiredawg wiredawg 3 years ago
      Why are you surprised? Serious question, not being impudent...
      👍️0
      rynlrt rynlrt 3 years ago
      200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
      👍️0
      Fofo812 Fofo812 3 years ago
      Surprised it held up this long
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Large tutes holdings. Some taking huge gains before years end.
      👍️0
      rynlrt rynlrt 3 years ago
      Not sure this kind of gain is sustainable. May see a big pullback
      👍️0
      Fofo812 Fofo812 3 years ago
      3rd post
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
      👍️0
      Trophy Trophy 5 years ago
      ..
      👍️0

      Your Recent History

      NASDAQ
      KRYS
      Krystal Biotech
      LSE
      SU72
      Mitsu Hc Cap.23
      TSXV
      LSC.P
      Lombard Street Capital
      LSE
      FM53
      Places Tr 33
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads